Analyst Ratings For ASND – Ascendis Pharma (NASDAQ:ASND)
Today, Leerink Swann raised its price target on ASND – Ascendis Pharma (NASDAQ:ASND) to $64.00 per share.
Some recent analyst ratings include
- 2/26/2018-Wedbush Reiterated Rating of Outperform.
- 1/19/2018-HC Wainwright Reiterated Rating of Buy.
- 9/22/2017-Wells Fargo Reiterated Rating of Buy.
Recent Trading Activity for ASND – Ascendis Pharma (NASDAQ:ASND)
Shares of ASND – Ascendis Pharma closed the previous trading session at with 65.72000122070312 shares trading hands.